CCL2 and liver dysplastic nodule: Second, genetic deletion of inflammatory mediators, e.g., leukocyte-attracting chemokine, Monocyte chemotactic protein 1, or intercellular adhesion molecule, ICAM-1[37–39], attenuates the progression of DN in mice.